Results 41 to 50 of about 1,591,231 (284)

Making Rasch decisions: The use of Rasch analysis in the construction of preference based health related quality of life instruments [PDF]

, 2008
Objective: To set out the methodological process for using Rasch analysis alongside traditional psychometric methods in the development of a health state classification that is amenable to valuation.
Brazier, J., Coyne, K., Tsuchiya, A., Yang, Y., Young, T.   +4 more
core   +2 more sources

Disparities in Total Knee Replacement: Population Losses in Quality‐Adjusted Life‐Years Due to Differential Offer, Acceptance, and Complication Rates for African Americans

Arthritis care & research, 2018
Total knee replacement (TKR) is an effective treatment for end‐stage knee osteoarthritis (OA). American racial minorities undergo fewer TKRs than whites.
Hannah M. Kerman, Savannah R. Smith, Karen C. Smith, J. Collins, L. Suter, J. Katz, E. Losina   +6 more
semanticscholar   +1 more source

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms [PDF]

, 2014
Aim In the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF), aldosterone blockade with eplerenone decreased mortality and hospitalisation in patients with mild symptoms (New York Heart Association class II ...
Akehurst, R., Cowie, M.R., Krum, H., Lee, D., McMurray, J.J.V., Pitt, B., van Veldhuisen, D.J., Vincent, J., Wilson, K., Zannad, F.   +9 more
core   +3 more sources

Exploring Preferences for a Digital Single‐Session Intervention for Adolescent Siblings of Youth With Cancer

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Adolescent siblings of children with cancer are at elevated risk for psychosocial problems. Unfortunately, various barriers such as limited family time and resources, conflicting schedules, and psychosocial staffing constraints at cancer centers hinder sibling access to support.
Christina M. Amaro, Sarah Silver, Prishi Patel, Meredith K. Reffner Collins, Kimberly S. Canter, Stephanie Fooks‐Parker, Michael Amylon, Shawna V. Hudson, Jessica L. Schleider, Melissa A. Alderfer, Katie A. Devine   +10 more
wiley   +1 more source

Income-related inequality in life-years and quality-adjusted life-years [PDF]

Journal of Health Economics, 2000
We estimate the income-related inequality in Sweden with respect to life-years and quality-adjusted life-years (QALYs). We use a large data set from Sweden with over 40,000 individuals followed up for 10-16 years, to estimate the survival and quality-adjusted survival in different income groups.
Gerdtham, Ulf-G., Johannesson, Magnus
openaire   +3 more sources

The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study [PDF]

, 2009
Background Recent data have shown that type 2 diabetes patients in the UK delay initiating insulin on average for over 11 years after first being prescribed an oral medication.
Gordon Goodall, Eric M Sarpong, Clarice Hayes, William J Valentine, American Diabetes Association, B Jonsson, R Williams, A Liebl, D Wanless, Y Ohkubo, The DCCT Research Group, The UK Prospective Diabetes Study Group, The UK Prospective Diabetes Study Group, The Diabetes Control and Complications Trial-Epidemiology of Diabetes Interventions and Complications Research Group, ML Lawson, IM Stratton, The ADVANCE Collaboration Group, E Selvin, American Diabetes Association, HC Gerstein, DM Nathan, DG Marrero, MJ Calvert, MJ Calvert, AJ Palmer, AJ Palmer, P Clarke, C Mathers, TO Tengs, National Institute for Clinical Excellence, RR Holman, H Yki-Jarvinen, MN Cook, A Rubino, LG Mellbin, K Malmberg, SL Bowker, LG Hemkens, U Smith, SH Saydah, GT Higgins, C Bebb, M Peyrot, A Phillips   +43 more
core   +1 more source

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman, Madeleine King, Rajen Mody, Sara‐Jane Onyeama, Araz Marachelian, Thomas Cash, Sara M. Federico, Meaghan Granger, Ami V. Desai, Suzanne Shusterman, Jennifer H. Foster, Elizabeth Sokol, Chelsee Greer, Keri Streby, Holly J. Meany, Kieuhoa T. Vo, Margaret E. Macy, Rochelle Bagatell   +17 more
wiley   +1 more source

The Proposal and Application of Quality-adjusted Life Years

Yixue yu zhexue
Quality-adjusted life years (QALYs) is a quantitative health measure that integrates both life expectancy and quality, proposed in the 1970s as an effective tool for aiding the rational allocation of healthcare resources while balancing efficiency and ...
Yixuan LI
doaj   +1 more source

Measuring the impact of alcohol-related disorders on quality of life through general population preferences

Gaceta Sanitaria, 2017
Objective: To estimate the intangible effects of alcohol misuse on the drinker's quality of life, based on general population preferences Methods: The most important effects (dimensions) were identified by means of two focus groups conducted with ...
Eva Rodríguez-Míguez, Jacinto Mosquera Nogueira   +1 more
doaj   +1 more source

Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities?

PharmacoEconomics (Auckland), 2017
BackgroundThere is a debate in the health economics literature concerning the most appropriate way of applying Amartya Sen’s capability approach in economic evaluation studies.
P. Mitchell, S. Venkatapuram, J. Richardson, A. Iezzi, J. Coast   +4 more
semanticscholar   +1 more source